Overview

Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response

Status:
Recruiting

Trial end date:
2021-05-15

Target enrollment:

Participant gender:

Summary

Non-inferiority, multicenter, prospective double-blind, randomized clinical trial of two parallel groups. The randomization between the 2 study groups will be carried out according to a scheme generated by a computer program, in blocks of 6 and stratified by centers. The antibiotic treatment will be evaluated during 5 days compared to the usual antibiotic treatment for more than 7 days in patients with community-acquired pneumonia with a Pneumonia Severity Index IV-V severity score who present an adequate response in the first 4 days of hospital antibiotic treatment.

Phase:

Phase 4

Details

Lead Sponsor:

David Garcia Cinca

Collaborators:

Fundacion Clinic per a la Recerca Biomédica
Miquel Ferrer - Investigator Coordinator

Treatments:

Anti-Bacterial Agents
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination